Prudent Man Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Prudent Man Advisors's ELV Position: Q2 2026 in Review
Prudent Man Advisors increased its Elevance Health (ELV) stake by 12% in Q2 2026, buying an estimated $50.4K and bringing the position to 1,237 shares worth $478K. The position accounts for 0.11% of the portfolio, ranked #120.
Prudent Man Advisors first reported a position in ELV in Q2 2020 and has held it in 25 quarters since. The position peaked at $881K in Q2 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Prudent Man Advisors held 1,237 shares of Elevance Health worth $478K as of Q2 2026.
- Prudent Man Advisors bought 136 Elevance Health shares in Q2 2026, an estimated $50.4K.
- Elevance Health made up 0.11% of Prudent Man Advisors's portfolio in Q2 2026, its #120 holding.
- Prudent Man Advisors first reported a position in Elevance Health in Q2 2020 and has held it in 25 quarters since.
- Prudent Man Advisors's Elevance Health position peaked at $881K in Q2 2022.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Prudent Man Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.